4//SEC Filing
Bradner James E. 4
Accession 0001127602-24-004620
CIK 0000318154other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:50 PM ET
Size
6.6 KB
Accession
0001127602-24-004620
Insider Transaction Report
Form 4
AMGEN INCAMGN
Bradner James E.
EVP, R&D, & Chief Sci. Officer
Transactions
- Award
Common Stock
2024-02-09+13,806→ 22,393 total - Award
Common Stock
2024-02-09+8,587→ 8,587 total
Footnotes (2)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 2/9/2026, 2/9/2027 and 2/9/2028, respectively.
- [F2]These shares include the following RSUs granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan: 8,587 RSUs which will vest in installments of 2,833 on 2/9/2026, 2,834 on 2/9/2027, and 2,920 on 2/9/2028; and 13,806 RSUs which will vest in installments of 4,555 on 2/9/2026, 4,556 on 2/9/2027, and 4,695 on 2/9/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0002005159
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 7:50 PM ET
- Size
- 6.6 KB